|Description||Venture Capital Firm|
|Biomed Fund III, 11/11 ||$22M|
MB Venture Capital Fund
MB Venture Partners is a venture capital firm specializing in investments in all stages of development. The firm does not invest in healthcare services, healthcare IT, and AgBio opportunities. It prefers to invest in seed or early stage financing but select later- stage financing are also considered. The firm typically invests in life sciences sector including biotechnology and medical device companies with a focus on: product solutions for musculoskeletal diseases, products to alleviate human suffering, and molecular therapeutics. It seeks to invest in opportunities across the United States for musculoskeletal related investments and Southeast and Midwest regions for investments in biotechnology, medical devices companies, and non-musculoskeletal investments. MB Venture Partners was founded in 2001 and is based in Memphis, Tennessee.
MB Venture Partners Gathers $22M For New Biomed Fund (fis.dowjones.com) 
**OnBioVC Post 1,000** AxioMed Spine Corp.: Series D $15M (onbiovc.com)
Anulex Technologies, Inc.: Series E $18.3M (onbiovc.com)
Onyvax Raises Â£8 Million to Advance Development of Prostate Cancer Vaccine (onyvax.com)